发明名称 |
METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
摘要 |
Methods of treating disorders in which TFNα activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor α (hTNFα) are disclosed. The antibody may be administered with or without methotrexate. These antibodies have high affinity for hTNFα (e.g., Kd=10−8 M or less), a slow off rate for hTNFα dissociation (e.g., Koff=10−3 sec−1 or less) and neutralize hTNFα activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Kits containing a pharmaceutical composition and instructions for dosing, and preloaded syringes containing pharmaceutical compositions are also encompassed by the invention.
|
申请公布号 |
US2013004507(A1) |
申请公布日期 |
2013.01.03 |
申请号 |
US201213530363 |
申请日期 |
2012.06.22 |
申请人 |
ABBOTT BIOTECHNOLOGY LTD.;FISCHKOFF STEVEN A.;KEMPENI JOACHIM;WEISS ROBERTA |
发明人 |
FISCHKOFF STEVEN A.;KEMPENI JOACHIM;WEISS ROBERTA |
分类号 |
A61K39/395;A61M5/28;A61K31/519;A61K38/00;A61P1/00;A61P1/16;A61P3/10;A61P7/04;A61P9/00;A61P9/10;A61P11/00;A61P13/12;A61P17/02;A61P19/02;A61P19/06;A61P19/08;A61P25/00;A61P27/02;A61P29/00;A61P31/00;A61P35/00;A61P37/00;A61P37/02;A61P37/06;A61P37/08;C07K16/24 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|